Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $784.7 million.

  • Mesoblast's Liabilities and Shareholders Equity rose 1726.51% to $784.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 billion, marking a year-over-year increase of 444.27%. This contributed to the annual value of $784.7 million for FY2025, which is 1726.51% up from last year.
  • Latest data reveals that Mesoblast reported Liabilities and Shareholders Equity of $784.7 million as of Q2 2025, which was up 1726.51% from $653.3 million recorded in Q4 2024.
  • Mesoblast's Liabilities and Shareholders Equity's 5-year high stood at $784.7 million during Q2 2025, with a 5-year trough of $650.4 million in Q1 2023.
  • For the 5-year period, Mesoblast's Liabilities and Shareholders Equity averaged around $695.1 million, with its median value being $676.0 million (2022).
  • Per our database at Business Quant, Mesoblast's Liabilities and Shareholders Equity crashed by 1108.81% in 2022 and then skyrocketed by 1726.51% in 2025.
  • Mesoblast's Liabilities and Shareholders Equity (Quarter) stood at $704.4 million in 2021, then decreased by 5.16% to $668.1 million in 2022, then increased by 0.33% to $670.3 million in 2023, then dropped by 2.53% to $653.3 million in 2024, then increased by 20.11% to $784.7 million in 2025.
  • Its last three reported values are $784.7 million in Q2 2025, $653.3 million for Q4 2024, and $669.2 million during Q2 2024.